# The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients

> **NCT02583802** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Beijing University of Chinese Medicine** · enrollment: 150 (estimated)

## Conditions studied

- Intradialytic Hypotension

## Interventions

- **DRUG:** Ear pills
- **DRUG:** Shengmai capsule

## Key facts

- **NCT ID:** NCT02583802
- **Lead sponsor:** Beijing University of Chinese Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2015-10
- **Final completion:** 2015-12
- **Target enrollment:** 150 (ESTIMATED)
- **Last updated:** 2015-10-22

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02583802

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02583802, "The Clinical Study of Improving the Thirst and Hypotension of Hemodialysis Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT02583802. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*